Skip to main content
OpenTrials
Completed

NCT Number: NCT01982526

Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients

Ovarian reserve influenced by many factor but especially cysts like endometrioma. Anti mullerian hormone is recent marker for ovarian reserve. The investigators are searching ovarian reserve pre and post operatively by using antimullerian hormone of endometrioma patient who are operated for their cysts.

Completed

Looking for future studies?

Notify Me

Key information

Age range

17 year–42 year

Sex eligibility

Female

Study type

Observational

Primary location

Kanuni Sultan Suleyman Education and Research Hospital

Istanbul, 34303, Turkey (Türkiye)

About this study

long term results of the postoperative follow up for the endometrioma patients

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ultrasonographical symptomatic and benign cysts which has surgery indication.

Exclusion criteria

  • Over 42 years old, systemic endocrine disorder, history of ovarian surgery

Treatment and study plan

Primary outcomes

  1. Long term postoperative ovarian reserve outcomes of endometrioma patients by examining antimullerian hormone.

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Important dates

Study start
2012
Primary completion
2013
Study completion
2016
First posted
Nov 13, 2013
Registry last updated
Aug 10, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.